Endometriosis is characterized by the implantation and growth of endometriotic tissues outside the uterus. It is widely accepted the theory that endometriosis is caused by the implantation of endometrial tissue from retrograde menstruation; however, retrograde menstruation occurs in almost all women and other factors are required for the establishment of endometriosis, such as cell survival, cell invasion, angiogenesis, and cell growth. Immune factors in the local environment may, therefore, contribute to the formation and progression of endometriosis. Current evidence supports the involvement of immune cells in the pathogenesis of endometriosis. Peritoneal neutrophils and macrophages secrete biochemical factors that help endometriotic cell growth and invasion, and angiogenesis. Peritoneal macrophages and NK cells in endometriosis have limited capability of eliminating endometrial cells in the peritoneal cavity. An imbalance of T cell subsets leads to aberrant cytokine secretions and inflammation that results in the growth of endometriosis lesions. It is still uncertain whether these immune cells have a role in the initial cause and/or stimulate actions that enhance disease; however, in either case, modulating the actions of these cells may prevent initiation or disease progression. Further studies are needed to deepen the understanding of the pathology of endometriosis and to develop novel management approaches of benefit to women suffering from this disease.
Introduction
Endometriosis is characterized by the implantation and growth of endometriotic tissues outside the uterus, such as the peritoneal cavity. This disease affects approximately 10% of women of reproductive age. 1 The pathogenesis of endometriosis is still largely unknown. Sampson proposed that endometriosis is caused by the implantation of endometrial tissue from retrograde menstruation. 2 This theory is widely accepted; however, retrograde menstruation occurs in almost all women; therefore, other factors that enhance cell survival, cell invasion, angiogenesis, and cell growth are believed to be required for the establishment of endometriosis. Immune factors in the local environment may contribute to the formation and progression of endometriosis. In fact, many studies have demonstrated the relation between various types of immune cells and the pathogenesis of endometriosis. This is a review of the current knowledge of the involvement of immune cells in the pathogenesis of endometriosis. We will also describe a clinical implication of immune cells for the management of endometriosis.
Neutrophils in the pathogenesis of endometriosis
Recently, our group performed an animal study using a mouse model of endometriosis and demonstrated that depletion of neutrophils using anti-Gr-1 antibody reduced lesion formation. 10 In this study, neutrophil depletion, in the early stage but not in the late stage of disease development, reduced lesion formation, which suggests that neutrophils are essential for the initial formation of endometriosis but not for disease progression.
Mechanisms by which neutrophils enhance endometriosis
Several mechanisms by which neutrophils enhance endometriosis have been proposed but most of what we know is based on their expression of cytokines. Neutrophils produce pro-inflammatory cytokines, such as vascular endothelial growth factor (VEGF), 11 IL-8, 12 and CXCL10, 12 which may promote disease progression. We have shown that neutrophils that accumulate in ovarian endometrioma express IL-17A. In addition, IL-17A stimulates endometriotic stromal cells and increases their secretion of CXCL1, which recruits more neutrophils, inducing the perpetual inflammation characteristic of endometriosis. 13 More recently, however, neutrophil extracellular traps have been implicated in pathogenesis given that they have been shown to be more prevalent in the peritoneal cavity of endometriosis patients. 14 The specific actions of cytokines secreted by neutrophils and neutrophil extracellular traps in the pathogenesis of endometriosis are the topic of ongoing research.
Possible clinical applications
Regarding diagnosis or disease detection, many studies have aimed to find the correlation between the number of peripheral blood neutrophils and the presence or severity of endometriosis. The neutrophilto-lymphocyte ratio (NLR) has been proposed as a potential measure of disease severity. The NLR was positively correlated with the severity of endometriosis, and NLR combined with serum carbohydrate antigen (CA)125 level was indicative of disease progression and effective as a diagnostic tool for endometrioma. 15, 16 NLR was also found to be valuable for the diagnosis of endometriosis in patients with CA125-negative serum. 17 On the contrary, some studies did not find a correlation between NLR and the presence or severity of endometriosis. 18, 19 Further studies are warranted to explain this discrepancy. Regarding therapeutic strategies, neutrophils per se or CA125 are potential targets for controlling endometriosis, although such attempts have not been made yet.
Macrophages

Macrophages in the pathogenesis of endometriosis
The number of macrophages is elevated in the peritoneal fluid of women with endometriosis, 20 and a significant increase in macrophage numbers was also shown in the eutopic endometrium in women with endometriosis. 21 Using a rat model for endometriosis, Haber et al. demonstrated that macrophage depletion resulted in a reduction in the development and growth of endometrium implants. 22 This finding suggests that macrophages play essential roles in the establishment of disease and its progression. Several mechanisms are suggested by which macrophages are involved in the development of endometriosis, and we hereby introduce related evidence.
Induction of inflammation
In addition to the increase in their number, peritoneal macrophages from women with endometriosis are highly activated by nuclear factor-κβ 23 and produce higher levels of pro-inflammatory cytokines, such as tumor necrosis factor-α, IL-6, and IL-1β. 24 By secreting these factors, macrophages may promote the establishment of an inflammatory milieu favorable for endometriosis development.
Promotion of angiogenesis
Macrophages also promote angiogenesis, which is essential for the establishment of endometriosis. Peritoneal macrophages are known as a source of VEGF, 25 which promotes the growth of blood vessels in the endometriosis lesion. Further, Tie2-expressing macrophages, which are known as tumor-associated macrophages with high pro-angiogenic activity, are attracted to human endometriosis lesions and maintain the viability of newly formed vessels in endometriosis model mice. 26 Similarly, macrophage depletion 27 or the administration of bevacizumab, a recombinant-humanized monoclonal VEGF-A antibody, 28 resulted in reduced lesion formation in mouse model studies.
Direct effects on endometriotic cells
Recent evidence suggests that macrophages directly affect endometriotic cells and promote the disease. Co-culture with macrophages upregulates cell proliferation, 29, 30 the production of Regulated on Activation, Normal T cell Expressed and Secreted (RANTES), Granulocyte Macrophage Colony Stimulating Factor (GM-CSF), and Interleukin 1 receptor alpha chain (IL-1-RA), 29 clonogenicity, 31 invasiveness, 30, 31 and the activation of Stat3 in endometriotic stromal cells. 29 These results indicate that the growth of endometriotic lesions is enhanced by macrophages that directly affect endometriotic cells.
Reduced phagocytosis activity
Both the number of macrophages and their proinflammatory and pro-angiogenic properties are enhanced in endometriosis; however, many studies report that the phagocytic ability of macrophages is reduced in patients with endometriosis. For instance, it has been demonstrated that peritoneal macrophages isolated from patients with endometriosis were reduced in phagocytic ability, and the reduction was caused by the diminished expression of Cluster of differentiation 36 (CD36), a scavenger receptor. 32 Further, inhibition of CD36 reduced phagocytic ability and promoted the development of endometriotic lesions in the mouse model. 33 It is also reported that annexin A2 on macrophages is responsible for their phagocytic ability, and its expression is reduced in peritoneal macrophages from women with endometriosis. 34 Taken together, reduced macrophage-mediated phagocytic activity may contribute to the pathogenesis of endometriosis.
M1/M2 macrophages
In 2000, Mills and colleagues proposed a new paradigm for the classification of macrophages, M1 and M2. They observed that peritoneal macrophages, from naïve mice strains on a Th1 background (C57BL/6, B10D2), produced more nitric oxide after stimulation with interferon (IFN)γ or Lipopolysaccharides (LPS) than macrophages from mice strains on a Th2 background (BALB/c or DBA/2) 35 and termed them M1 and M2, respectively. Many researchers studying various diseases since this proposal have characterized macrophages according to this classification. In short, M1 macrophages are dominant in acute inflammatory status, whereas M2 macrophages are enhanced in cancer. Regarding endometriosis, Bacci et al. reported a significant increase of M2 macrophages in the peritoneal fluid from patients with endometriosis. 27 The authors also showed that intraperitoneal injection of M2 macrophage promoted endometriosis lesion growth in a mouse model. M2 polarization was also identified in rhesus macaque endometriosis. 36 Alternatively, Takebayashi et al. reported a higher M1/M2 ratio in the eutopic endometrium of patients with endometriosis. 37 Further functional characterizations have indicated that M2 macrophages in endometriosis express increased MMP-9, 38 MMP-27, 39 and have an increased IL-10/IL-12 ratio, 40 but MMP-1 and MMP-2 expression is lower than in controls. 38 Although characterization is not fully clarified, these results imply that certain subsets of M2 macrophages are responsible for the pathogenesis of endometriosis.
Macrophage and endometriosis-associated pain
In recent years, peripheral neuro-inflammation, a process characterized by the infiltration of nerve fibers and macrophages into endometriosis lesions, is known to play a pivotal role in endometriosis-associated pain. In endometriotic lesions, nerve fibers were co-located with concentrations of macrophages. 41 Further, estradiolmediated crosstalk between macrophages and nerve fibers from peritoneal endometriosis has been demonstrated. 42 Clearly, an understanding of the role of macrophages in the pain symptoms associated with endometriosis is in its infant stages and requires more investigation.
Dendritic cells
Dendritic cells are heterogeneous monocyte lineage cells responsible for antigen presentation. In comparison with macrophages, dendritic cells have a greater capacity for acquiring and processing antigens for presentation to T cells. They also express higher levels of co-stimulatory or co-inhibitory molecules than macrophages and, therefore, dendritic cells can determine immune activation or anergy. 43 In contrast to the work that has been published on the role of macrophages in endometriosis, the involvement of dendritic cells in the pathogenesis of endometriosis is not well clarified.
Animal studies using endometriosis mouse models
In 2008, Fainaru et al. demonstrated that injection of dendritic cells into the peritoneal cavity of endometriosis model mice promoted lesion formation and suggested that dendritic cells, by enhancing angiogenesis, contribute to the lesion growth. 44 Interestingly, two studies that followed using CD11c-DTR-GFP transgenic mice, whereby the dendritic cells are temporarily depleted using diphtheria toxin injection, 45 generated contradictory results. Pencovich et al. demonstrated that endometriotic lesion formation was reduced in their dendritic-cell depleted mice 46 ; however, Stanic et al. reported that depletion resulted in greater lesion size. 47 The study protocol, especially the timing of diphtheria toxin injection (depleting dendritic cells), may account for the difference in outcomes.
Frequency of dendritic cells in the lesion and peritoneal cavity of endometriosis patients
In terms of the frequency of dendritic cells in the lesion or peritoneal cavity, few differences in comparison with healthy tissue have been detected. The density of CD1a+ dendritic cells was significantly increased in peritoneal endometriotic lesions and in the surrounding peritoneum compared with eutopic endometrium and peritoneum distant from the lesion. 48 The frequency of peritoneal dendritic cells identified by the lineage − HLA-DR + CD11c + CD123 + , however, was not statistically different between patients with endometriosis and controls. 5 When subset analysis for the proportion of peritoneal dendritic cells was performed using specific surface antigens (BDCA1, BDCA2, and BDCA3), no significant difference was found between endometriosis and the control. 49 Mannose receptor on BDCA1 + dendritic cells in the pathogenesis of endometriosis Recently, our group reported that the frequency of mannose receptor (MR)-positive BDCA1 + dendritic cells in the peritoneal cavity is higher in endometriosis patients than in controls. 49 We further demonstrated that MR+ dendritic cells promote phagocytosis of dead endometrial cells and inflammation, and thereby contribute to the etiology of endometriosis. 49 Taking this idea one step further, modulating MR expression and/or activity may enable the regulation of immune responses and potentially help treat endometriosis, 50 although further studies are needed to explore how other dendritic cell subsets or receptors contribute to the pathogenesis.
Natural killer cells
Natural killer (NK) cells were originally described as one of the innate arms of the immune system that control tumor immunity and microbial infections. 51 In peripheral blood, human NK cells are divided into two types: the typical CD56 bright CD16 − NK cells that are characterized as high-level cytokine producers, and CD56 dim CD16 + NK cells that are characterized as highly cytotoxic. 52 
Reduced NK cell cytotoxic activity in endometriosis
With regard to endometriosis, the cytotoxic function is reduced in peripheral and peritoneal NK cells. [53] [54] [55] [56] [57] Due to diminished cytotoxicity, retrograde endometrial cells are prone to survive in the peritoneal cavity, which results in the development of endometriosis. Factors controlling NK cell function have not been thoroughly investigated; however, several studies have shown that IL-6, 57 IL-15, 58 and transforming growth factor-β1 59 suppress NK cell cytotoxic activity.
Activation of NK cells: Potential for a new therapy
Given that reduced cytotoxic function of NK cells is involved in the etiology of endometriosis, activation of NK cell cytotoxicity is a possible new treatment strategy for endometriosis. Itoh et al. conducted mouse model experiments and found that the oral administration of probiotics activates peritoneal NK cells, and reduces endometriotic lesion formation. 60 Further, an extract of the white mistletoe tree, Helixor A, also directly activates NK cell cytotoxicity. 56 By adapting a strategy for cancer immunotherapy, 61 Montenegro et al. administered intraperitoneal injections of IL-2-activated NK cells and reduced lesion formation in a mouse endometriosis model. 62 In this manner, progress in developing cancer immunotherapies may provide new therapeutic options for endometriosis, and further development is expected.
T cells
CD4+ T cells differentiate into helper T cell subsets and induce a distinctive immune response. Classically, helper T cells have been classified into two subsets, Th1 and Th2 T cells, characterized by their secretion of IFNγ and IL-4, respectively. 63 More recently, Th17 and regulatory T cells (Treg) have been identified as new CD4 T cell subsets. [64] [65] [66] Additionally, CT8+ T cells, which include cytotoxic T lymphocytes and provide defense against virus-infected cells and tumors, were included in the classification. 67 These classifications have assisted a greater understanding of the immune system and the pathogenesis of many diseases.
68
Th1/Th2 imbalance in endometriosis
As described earlier, studies of macrophages have shown that M2 polarization is associated with the development of endometriosis, and Th2 have been assumed to cause disease progress. 69 Indeed, studies of cytokine levels in peritoneal fluid demonstrated increased IL-10, 70 decreased IFNγ, 70 and increased the IL-4/IFNγ ratio. 71 It has been shown that cytokine secretion by peritoneal T cells is characteristic of Th2 in endometriosis tissue. 72 In the endometriosis lesion, the frequency of Th1 cells is lower than in normal endometrium. 73 Furthermore, Th2 cytokines, such as IL-4, 74-76 IL-10, 77 and TSLP, 78 have been shown to contribute to disease progression. Studies of peripheral blood, however, have revealed a higher Th1/Th2 cytokine ratio 79 and Th1 cell frequency 73 in endometriosis patients compared with controls. The discrepancy between the local and systemic Th1/Th2 balance remains unresolved.
Th17 and Treg in endometriosis
Th17 are one of the helper T cell subsets and they are defined by their production of IL-17a, a proinflammatory cytokine. The frequency of Th17 in endometriosis lesions is higher than in that of the normal endometrium, 73 and their high frequency in peritoneal fluid is associated with the increased severity of disease. 80 IL-17a is also described as an aggravator of endometriosis because it exacerbates inflammation and endometriotic cell proliferation. [81] [82] [83] More research is required to clarify the role of Th17 in disease progression.
Treg is another subset of helper T cells and they are known to maintain immunological tolerance. 66 Many studies have shown that Treg are increased in the peritoneal cavity of endometriosis patients [84] [85] [86] [87] ; however, two studies did not find a significant difference. 73, 88 In a mouse study, the inhibition of Treg induction (differentiation) reduced the number and weight of endometriotic lesions. 87 These findings indicate that Treg play a role in endometriosis progress, although further studies are required to discover the mechanism and therapeutic targets.
Cytotoxic T cells in endometriosis
Analysis of peritoneal fluid revealed that the population of cytotoxic T cell is higher 89 and the CD8/CD4 ratio is increased 72, 90 in endometriosis patients in comparison with controls. A recent study showed that the peripheral cytotoxic T cell concentration increases in the luteal phase and decreases in the follicular phase in healthy controls, whereas these fluctuations were not observed in endometriosis patients, 91 implying that cytotoxic dysregulation is associated with endometriosis progression. As for clinical application, Melioli et al. proposed that cytolytic activity could be restored with administering recombinant IL-2, 92 although clinical studies have not yet been conducted. Further studies are needed to determine whether cytotoxic T cells would be a therapeutic target.
Conclusion
Current evidence supports that immune cells are integral to the pathogenesis of endometriosis. Peritoneal neutrophils and macrophages secrete biochemical factors that help endometriotic cell growth and invasion, and angiogenesis. Peritoneal macrophages and NK cells in endometriosis have limited capability of eliminating endometrial cells in the peritoneal cavity. An imbalance of T cell subsets leads to aberrant cytokine secretions and inflammation that results in the further growth of endometriosis lesions. It is still uncertain whether the activity of these immune cells causes endometriosis or whether they act as secondary enhancers of the disease; however, in either case, modulating the actions of these immune cells may prevent the initiation or progress of endometriosis. Further studies are needed to deepen the understanding of endometriosis pathology, and to develop novel approaches to benefit women suffering from this disease.
